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Purpose.0e aim of this study was to compare the pain severity, health-related quality of life (HRQoL), and risk of continue having
pain with prognostic risk scores (PRS), between patients referring greater trochanteric pain syndrome (GTPS) and chronic low
back pain (CLBP). Methods. A descriptive, cross-sectional design using nonprobability convenience sampling was performed. A
total sample of 102 patients were recruited from two primary health-care centers and divided into GTPS (n � 51) and CLBP (n �
51) groups.0e primary outcome was pain severity which was assessed with the Spanish version of the Graded Chronic Pain Scale
(GCPS). 0e secondary outcome was the HRQoL which was measured using the Spanish version of EuroQoL Five Dimensions
and Five Levels (EQ-5D-5L) as well as the PRS. Results. Signiﬁcant diﬀerences (P<0.05) were found within both groups in the pain
severity global score with a medium eﬀect size showing greater values for the CLBP group with regards to the GTPS group. 0e
PRS in both groups did not show statistical diﬀerences (P>0.05). Nevertheless, subjects referring CLBP showed greater levels in the
PRS than patients with GTPS. Comparing both groups, the HRQoL showed statistical diﬀerences (P<0.05) in the “pain/dis-
comfort” domain in the CLBP group with respect to the GTPS group, but not in the other domains. Conclusions. Patients who
suﬀered from CLBP showed greater pain severity and HRQoL discomfort with regard to patients with GTPS. Despite greater
scores for CLBP, the PRS did not seem to be diﬀerent between both conditions.
1. Introduction
Worldwide, chronic low back pain (CLBP) may be con-
sidered as one of the main musculoskeletal conditions,
which causes disability for the life years [1]. CLBP is fre-
quently referred to primary care and physical therapy units
[2]. Up to 40% of the population will experience CLBP [3].
0e CLBP prevalence increased during the last years with
older age distributions and may be associated with the
increase of psychological factors such as anxiety or de-
pression [4–6]. Pain severity, disability, and health-related
quality of life (HRQoL) did not seem to be associated with
degenerative radiological modiﬁcations of the lumbar spine
[7]. 0e socioeconomic factors may predict the CLBP dis-
ability process more than medical-biological characteristics
and generate a strong impact in the Spanish primary care [8].
Recently, the greater trochanteric pain syndrome
(GTPS) appeared as a common nonosteoarthritic hip
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condition reported usually in the primary health-care
services [9–11]. 0is syndrome comprised signs and
symptoms such as a lateral hip pain history as well as
pain on lateral hip palpation, among other factors [9].
0e GTPS prevalence reached 20.2% of the patients
referred from primary care to a tertiary care orthopedic
spine center. 0is syndrome was more commonly re-
ported in women than in men, and the magnetic reso-
nance imaging was not frequently associated with
neurological ﬁndings [12]. In Spain, there is a lack of
GTPS prevalence studies, and this may be secondary to
the diﬀerential diagnosis challenge of lateral hip pain
[10]. Among the musculoskeletal conditions, the GTPS
may interfere with the HRQoL and the pain severity of
patients referred from the primary health-care system
[13].
Indeed, GTPS comprised patients’ substantial pro-
portion referred from primary health care in order to
evaluate CLBP. Primary care physicians should be able to
stablish an early diagnosis and prognosis in order to reduce
costly patient referrals and avoid unnecessary surgery
[12, 14]. GTPS and CLBP may reduce HRQoL and increase
the pain severity as well as complicate the prognosis of
primary care patients [13]. Indeed, CLBP was shown to be
the musculoskeletal condition which generated the greater
disability adjusted by life years impairing the healthy life
expectancy as well as high chronic pain severity and
HRQoL impairment [1, 13]. Nevertheless, up to date prior
studies have not speciﬁcally compared both common
conditions with regard to HRQoL, pain severity, and their
prognostic risk scores (PRS) in primary care environments.
Although chronic musculoskeletal conditions showed
a clearly detrimental eﬀect on the HRQL and the burden of
musculoskeletal conditions has been compared with other
common chronic diseases [13], the comparison of pain
severity levels and quality of life between patients groups
with CLBP and GTPS needs to be addressed. We hy-
pothesize that patients with CLBP may show a higher pain
severity, a greater impairment of HRQoL, and a higher risk
of continue having pain with worse PRS than patients who
suﬀer from GTPS. 0erefore, the aim of the present study
was to compare the pain severity, HRQoL, and risk of
continue having pain with PRS measures, between patients
referring GTPS and CLBP.
2. Methods
2.1. StudyDesign. A descriptive, cross-sectional design using
nonprobability convenience sampling was performed. All
participants were recruited since September 2016 to Feb-
ruary 2017 and diagnosed as GTPS or CLBP by the refer-
enced general practitioner from two primary health-care
centers in Madrid, Spain, and were derived to the physical
therapy unit. All the subjects gave their written informed
consents. 0is study was accepted by the Southeast Local
Research Committee of the Primary Health Care Manage-
ment (Code 16/15). 0e reporting of the study followed the
“STrengthening the Reporting of OBservational studies in
Epidemiology” (STROBE) guidelines [15].
2.2. Subjects. 0e inclusion criteria for the present study
were (1) patients referring low back pain [5, 6] or (2) patients
with unilateral lateral hip pain [16], (3) tenderness on
palpation at the greater trochanter [9], (4) being diagnosed
and derived by a general practitioner, and (5) having pain
almost until last 3 months before the assessment time.
0e exclusion criteria were (1) presence of other mus-
culoskeletal injury, neurological, or systemic condition that
could aﬀect balance/gait [16], (2) cognitive impairment or
psychiatric disease, or (3) having surgical or traumatic
history or corticoid local injection in previous six months.
2.3. Data Collection. A sociodemographic questionnaire
containing gender, age, height, weight, civil state, level of
education, and pain intensity was self-reported by the study
participants.
2.3.1. Primary Outcome
Pain Severity. 0e pain severity was assessed by means of the
Spanish version of the Graded Chronic Pain Scale (GCPS).
0is scale is a self-reported instrument consisting of two
subscales; the ﬁrst scale evaluates the pain intensity, and the
second scale assesses the perceived disability. 0e scale is
formed by a total of 8 items, 7 of them are 11 points as Likert
format, and the other item evaluates the perpetuation of
pain, asking the number of pain days in the previous
6 months. 0e Spanish version of the GCPS has proven to be
a valid and reliable instrument for assessing the severity of
chronic pain. Concretely, high internal consistency (Cron-
bach’s α � 0.87) and intraclass correlation coeﬃcient (ICC �
0.81) have been described [17]. 0e total score of the scale
ranges from 0 to 70 points, the chronic pain perpetuation
with the ﬁrst item, and also have a graduation in ﬁve levels
with its punctuation [18].
2.3.2. Secondary Outcomes
Health-Related Quality of Life (HRQoL). It was measured
by the Spanish version of EuroQoL Five Dimensions and
Five Levels (EQ-5D-5L). 0is self-reported questionnaire
has been widely used in the literature to report perceived
health quality of life in many conditions and translated into
130 languages [19–21]. 0e instrument consists of two el-
ements, the ﬁrst one is a 5-item questionnaire, one for each
domain assessed (mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression), and ﬁve levels on each
domain (no problems, slight problems, moderate problems,
severe problems, and extreme problems). Patients were
asked to ﬁll only one level on each domain (1 to 5).0e digits
on each domain can be combined on a ﬁve digit number
ranging from 11111 to 55555. Also, the EQ-5D-5L results
can be interpreted by the Sum Score that it is a severity index
obtained with the summation of the levels in each dimension
of the instrument, subtracting 5 points and multiplying the
result by 5. It results on a 0-to-100 range new scale where
more points mean more severity. Another way to interpret
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the results on the EQ-5D-5L is by means of the Index
(EQ-Index); this approach compares the values in the ﬁve
dimensions with 3125 diﬀerent hypothetic health states
adjusted by country population, being the “0” value assigned
to death and “1” to the perfect health status. Values less than
0 are considered in the index, being those statuses inter-
preted as “worse than being dead.”
0e second part of the questionnaire is a vertical 20 cm
Visual Analogue Scale (EQ-VAS) in which subjects are asked
to self-rate their health, from 0 “0e worst health you can
Imagine” to 100 “0e best health you can imagine.” Finally,
the Spanish EQ-5D-5L presented minimal ﬂoor and ceiling
eﬀects (<3%) and a Cronbach’s α of 0.86 [22].
Prognostic Risk Score (PRS). 0e PRS is an instrument to
determine the probability of having pain in the next years.
0is tool is based on the perspective of a chronic pain
continuum health status, nor a unique state of the subjects
who referred pain during 3 or 6 months (as the conventional
deﬁnition of chronic pain). It was calculated for each subject
with the rules proposed by Von Korﬀ and Miglioretti [23]
and used in other studies [24, 25] with the scoring method
described in Table 1. 0e cut-points were also established in
low risk, intermediate risk, possible risk over 50%, and
probable risk over 80% for the probability of having pain in
the next 5 years in primary health-care samples [23]. In
addition, a high level of reliability was demonstrated for the
classiﬁcation of people at high risk (over 80% probability) for
suﬀering from clinically signiﬁcant back pain at follow-up
[24, 25].
2.4. Pain Intensity. 0e average pain intensity in the last
seven days was measured by means of a Visual Analogue
Scale (VAS). 0is scale consists of a horizontal 100mm line,
in which the patients must indicate their pain intensity. At
the left side of the line appears the text “no pain” and at the
right side appears “worst possible pain.”0is instrument had
demonstrated its validity and reliability measuring the pain
intensity, showing ICCs among pain scales from 0.65 to 0.88
with a median r of 0.74 [26, 27].
2.5. Sample Size. Sample size was calculated with the
G∗Power 3.1.9.2 for Mac OS X (G∗Power© from University
of Du¨sseldorf, Germany) to determine a suﬃcient sample
size considering a one-tailed t-test with two groups and
a medium eﬀect size to achieve clinically relevant diﬀerences
(d � 0.50) in the primary variable (pain severity) to obtain
a statistical power of 80% using an α error of 0.05. Based on
the aforementioned assumptions, we estimated a sample size
of at least 102 subjects [28].
2.6. Data Analysis. Data analyses were performed on SPSS
for Mac OS X, Version 22.0 (SPSS Inc., Chicago IL) with
a 95% conﬁdence interval (CI) and considering statistically
signiﬁcant diﬀerences if P value < 0.05. Parametric tests were
used because the sample size (greater than 30 subjects per
group) was suﬃcient to be supported by the central limit
theorem [29]. 0e continuous variables are presented as
mean and standard deviation (SD), and the categorical
variables are presented as absolute numbers and relative
frequency (i.e., percentages). A Student’s t-test for in-
dependent samples was used to compare the quantitative
outcomes between subjects with GTPS and CLBP, and the
chi-square test was used for the categorical ones. Further-
more, the eﬀect sizes of the primary outcomes were cal-
culated based on the following formula d � 2t/
���
gdl
√
, which
is determined by the SD of the groups. Cohen’s d size eﬀect
may be interpreted as slight (d lower than 0.20), fair (d from
0.20 to 0.49), moderate (d from 0.50 a 0.79), or large (d equal
or higher than 0.80) [30].
3. Results
3.1. Sociodemographic Characteristics. A total sample of one
hundred and two subjects were analyzed in this study and
divided into two groups, one group of patients diagnosed of
GTPS (n � 51) and another group of patients with CLBP (n �
51). Sociodemographic variables did not show any statisti-
cally signiﬁcant diﬀerence (P> 0.05) between both groups.
Descriptive variables of both groups are presented in Ta-
bles 1 and 2.
3.2. Primary Outcome. Regarding Student’s t-test, a statis-
tical signiﬁcant diﬀerence (P< 0.05) was found between both
groups in the pain severity global score with a medium eﬀect
size (mean diﬀerence � −7.49; CI 95% from −13.35 to −1.62;
d � 0.51) showing greater values of the CLBP group with
regard to the GTPS group. 0e results of the comparison for
the other quantitative variables are presented in Table 3.
3.3. SecondaryOutcomes. 0e chi-square test comparing the
PRS in both groups did not show statistical diﬀerences, as
presented in Table 4. Nevertheless, subjects referring CLBP
showed greater levels in the PRS than patients with GTPS.
Levels of both groups with the cutoﬀ points for primary
health-care samples are presented in Table 4 and Figure 1.
Moreover, the chi-square test comparing the HRQoL
between groups showed statistical diﬀerences (P< 0.05) in
the “pain/discomfort” domain of the CLBP group with
respect to the GTPS group, but not in the other domains, as
presented in Table 5.
4. Discussion
To the authors’ knowledge, this may be considered as the
ﬁrst study comparing both common conditions, CLBP and
GTPS. CLBP seemed to show greater pain severity and
HRQoL discomfort with respect to GTPS. 0e prognostic
risk seemed to be similar between both musculoskeletal
pathologies. Despite this, there is a tendency towards poorer
quality of life, higher pain severity, and prognostic risk in the
patients who suﬀer from CLBP with regard to patients who
suﬀer from GTPS. 0ese ﬁndings coincide with prior re-
search about musculoskeletal conditions related to quality of
life and pain severity [1, 7–9, 12, 13].
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Here, we show a challenge in the diﬀerential diagnosis
between both conditions which may commonly be con-
sidered as comorbidities in patients referred to primary
health-care and physical therapy units [2, 12–14]. 0erefore,
the palpation skills and the clinical reasoning of physicians
and physical therapists should be improved in order to
diagnose and classify these primary care patients, avoid
unnecessary costs, and provide interventions according to
the HRQoL discomfort and pain severity [9–11, 13].
4.1. Implications for Clinical Practice. Although both CLBP
and GTPS conditions may be focused as main musculo-
skeletal disorders for treating in primary health-care envi-
ronments [12, 14], patients who suﬀer from CLBP need
greater primary care attention to reduce pain severity and
increase HRQoL with regard to patients who suﬀer from
GTPS. Interventions such as multidisciplinary rehabilitation
approaches should be prioritized in this kind of patients who
attend to primary health-care units [31].
Table 1: Description of quantitative sociodemographic variables between GTPS and CLBP groups.
GTPS group (n � 51) CLBP group (n � 51)
P value (Student’s t-test)Mean ± SD Mean ± SD
Age (years) 48.88 ± 8.52 52.43 ± 12.34 0.095
BMI 26.89 ± 5.53 29.03 ± 5.60 0.054
Pain days, last 6 months 119.31 ± 62.21 136.03 ± 53.80 0.330
Pain intensity (VAS) 35.19 ± 23.56 40.10 ± 23.91 0.150
Chronicity (months) 28.52 ± 47.04 58.22 ± 90.44 0.065
GTPS, greater trochanteric pain syndrome; CBLP, chronic low back pain; SD, standard deviation; BMI, body mass index.
Table 2: Description of categorical sociodemographic variables between GTPS and CLBP groups.
GTPS group (n � 51), n (%) CLBP group (n � 51), n (%) P value (chi-square test)
Gender
Male 9 (17.6%) 18 (35.3%) 0.463Female 42 (82.4%) 33 (64.7%)
Civil state
Single 12 (23.5%) 9 (17.6%)
0.218Married 33 (64.7%) 28 (54.9%)Divorced 4 (7.8%) 7 (13.7%)
Widower 2 (3.9%) 7 (13.7%)
Education level
None 0 (0%) 2 (3.9%)
0.347Primary 15 (29.4%) 19 (37.3%)Secondary 18 (35.3%) 17 (33.3%)
University 18 (35.3%) 13 (25.5%)
All data are presented as number and percentage (n(%)). GTPS, greater trochanteric pain syndrome; CLBP, chronic low back pain; ∗P< 0.05.
Table 3: Comparison of quantitative result variables between GTPS and CLBP groups.
GTPS group (n � 51) CLBP group (n � 51) Mean diﬀerences 95% of CI Eﬀect size (Cohen’s d)Mean ± SD Mean ± SD
EuroQoL-5D value index 0.683 ± 0.200 0.689 ± 0.201 2.02 −6.34 To 10.38 0.03
EuroQoL-5D VAS 66.73 ± 22.96 64.70 ± 19.45 −0.006 −0.085 To 0.072 0.10
EuroQol-5D sum score 23.03 ± 14.56 24.31 ± 14.52 −1.27 −6.98 To 4.43 0.08
GCPS total score 28.11 ± 14.74 35.60 ± 15.11 −7.49 −13.35 To −1.62 0.51∗
Prognostic risk score 14.21 ± 5.78 16.47 ± 5.34 −2.25 −4.44 To −0.06 0.42
SD, standard deviation; CI, conﬁdent interval; VAS, Visual Analogue Scale; GCPS, Graded Chronic Pain Scale; GTPS, greater trochanteric pain syndrome;
CBLP, chronic low back pain; ∗P< 0.05.
Table 4: Description of the prognostic risk score Categories between GTPS and CLBP groups.
Prognostic risk score GTPS group (n � 51) CLBP group (n � 51) P value (chi-square test)
Low risk 7 (13.7%) 2 (3.9%)
0.233Intermediate risk 21 (41.2%) 18 (35.3%)Possible chronic pain (50% risk) 15 (29.4%) 19 (37.3%)
Probable chronic pain (80% risk) 8 (15.7%) 12 (23.5%)
GCPS, Graded Chronic Pain Scale; GTPS, greater trochanteric pain syndrome; CBLP, chronic low back pain.
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Figure 1: Number of subjects and the relation between GTPS and CLBP patients in PRS. CLBP, chronic low back pain; GTPS, greater
trochanteric pain syndrome; PRS, prognostic risk scores.
Table 5: Descriptive data and of ve dimensions of EQ-5D and comparison between the GTPS and CLBP groups.
EQ-5D dimension Groups P value (chi-square test)
GTPS group (n  51) CLBP group (n  51)
Mobility
No problem 16 (31.4%) 17 (33.3%)
0.308
Slight problem 19 (37.3%) 23 (45.1%)
Moderate problem 13 (25.5%) 10 (19.6%)
Severe problem 3 (5.9%) 0 (0%)
Unable to 0 (0%) 1 (2%)
Self-care
No problem 38 (74.5%) 38 (74.5%)
0.783
Slight problem 6 (11.8%) 6 (11.8%)
Moderate problem 7 (13.7%) 6 (11.8%)
Severe problem 0 (0%) 1 (2%)
Unable to 0 (0%) 0 (0%)
Usual activities
No problem 18 (25.3%) 23 (45.1%)
0.436
Slight problem 23 (45.1%) 15 (29.4%)
Moderate problem 9 (17.6%) 12 (23.5%)
Severe problem 1 (2%) 1 (2%)
Unable to 0 (0%) 0 (0%)
Pain/discomfort
No problem 4 (7.8%) 1 (2%)
0.024∗Slight problem 21 (41.2%) 13 (25.5%)Moderate problem 16 (31.4%) 31 (60.8%)
Severe problem 10 (19.6%) 6 (11.8%)
Unable to 0 (0%) 0 (0%)
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4.2. Limitations. Several limitations and methodological
aspects should be taken into account regarding the present
research. First, physical factors, such as pressure pain
thresholds [32], recurrence or physical disability [7], were
not assessed. Second, age distributions were not evaluated
and may inﬂuence psychological aspects [5]. 0ird, acute
and subacute low back pain or GTPS were excluded to
include the central sensitization, which commonly occurs in
a longer-term process [9, 17, 33]. Although the presence of
prior surgeries was an inclusion criterion, former pain ex-
periences of the subjects were not collected and should be
considered for future research studies. Finally, individuals
from various countries diﬀerent from Spain and larger
sample sizes may be beneﬁcial to reach a study power im-
provement and ﬁnd variations among countries [1].
5. Conclusions
Patients who suﬀered from CLBP showed greater pain se-
verity and HRQoL discomfort with regard to patients with
GTPS. Despite greater scores for CLBP, the PRS did not
seem to be diﬀerent between both conditions.
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